Home β€Ί Stock analysis β€Ί ASBP

Aspire-Lakewood (ASBP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

ASBP rises 1.6% to $8.78. Closed at $8.78, +1.62% vs the prior close of $8.64. Day range $8.16–$8.97, opened at $8.43.

Last close$8.78+1.62%
Day range8.16–8.97
Open8.43
Volume34.83K
52-week range0.11–18.76
Avg volume (20d)34.09K

ASBP daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” ASBP rises 1.6% to $8.78
Oct 15, 2026 β€” ASBP jumps 5.9% to $8.64
Oct 14, 2026 β€” ASBP ends flat (-0.2%) to $8.16 on 2.7x normal volume
Oct 13, 2026 β€” ASBP jumps 5.1% to $8.18
Oct 12, 2026 β€” ASBP slides 6.3% to $7.78, a 1-month low, 5 down days in a row
Oct 9, 2026 β€” ASBP ends flat (+0.0%) to $8.30, 4 down days in a row
Oct 8, 2026 β€” ASBP slides 3.8% to $8.30 on 2.5x normal volume
Oct 7, 2026 β€” ASBP dips 1.5% to $8.63
Oct 6, 2026 β€” ASBP dips 1.4% to $8.76
Oct 5, 2026 β€” ASBP rises 1.1% to $8.88
Oct 2, 2026 β€” ASBP jumps 8.1% to $8.78

ASBP latest news & SEC filings

Every SEC filing by or about ASBP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 29, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-044908

Sep 9, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-041918

Sep 8, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-041725

Aug 19, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-039135

Aug 14, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000919574-26-005317

Aug 13, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001493152-26-037819

Aug 10, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001213900-26-087424

Aug 10, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-036777

Aug 6, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001493152-26-036445

Jul 20, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-033942

Jul 2, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0002142929-26-000001

Jun 22, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-029599

Things to know before you trade ASBP

ASBP market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20268.438.978.168.7834.83K
Oct 15, 20268.108.887.988.6431.90K
Oct 14, 20268.208.457.188.1687.10K
Oct 13, 20267.808.507.808.1836.10K
Oct 12, 20268.368.577.667.7822.30K
Oct 9, 20268.678.678.108.3034.10K
Oct 8, 20268.769.008.258.3078.50K
Oct 7, 20268.598.938.578.6312.40K
Oct 6, 20268.889.098.758.7627.70K
Oct 5, 20268.678.888.408.8820.30K
Oct 2, 20268.368.818.338.7816.50K
Oct 1, 20268.438.438.108.1223.00K
Sep 30, 20268.638.638.108.3511.20K
Sep 29, 20268.448.508.168.188.40K
Sep 28, 20268.319.238.318.5055.90K
Sep 25, 20268.578.588.138.3232.70K
Sep 24, 20268.208.887.958.7043.00K
Sep 23, 20268.298.838.268.3331.30K
Sep 22, 20268.848.848.078.2065.50K
Sep 21, 20268.868.908.668.729.00K

About Aspire-Lakewood

Aspire-Lakewood (ASBP) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in ESTERO, FL. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1847345.

ASBP board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

ASBP financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$6.20K$-24.48M-16.38$-4.92M
Dec 31, 2024β€”$-1.31M-1.90$-265.19K
Dec 31, 2023β€”$4.46Mβ€”$-653.11K
Dec 31, 2022β€”$3.34Mβ€”$-1.41M
Dec 31, 2021β€”$-25.48Kβ€”$-238.60K

Latest balance sheet: total assets $13.54M, total liabilities $1.78M, cash $12.17M (as of Jun 30, 2026).

ASBP earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on ASBP

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.